title: Addition of aprepitant to standard therapy for prevention of nausea and vomiting among patients with cervical cancer undergoing concurrent chemoradiotherapy.
authors.affiliation: Department of Obstetrics and Gynecology, Nara Medical University, Nara, Japan. Electronic address: kawaryu@naramed-u.ac.jp.
authors.forename: Ryuji
authors.initials: R
authors.lastname: Kawaguchi
authors.affiliation: Department of Obstetrics and Gynecology, Nara Medical University, Nara, Japan.
authors.forename: Yasuhito
authors.initials: Y
authors.lastname: Tanase
authors.affiliation: Department of Obstetrics and Gynecology, Nara Medical University, Nara, Japan.
authors.forename: Shoji
authors.initials: S
authors.lastname: Haruta
authors.affiliation: Department of Obstetrics and Gynecology, Nara Medical University, Nara, Japan.
authors.forename: Shozo
authors.initials: S
authors.lastname: Yoshida
authors.affiliation: Department of Obstetrics and Gynecology, Nara Medical University, Nara, Japan.
authors.forename: Naoto
authors.initials: N
authors.lastname: Furukawa
authors.affiliation: Department of Obstetrics and Gynecology, Nara Medical University, Nara, Japan.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Kobayashi
mesh_terms: D000932:Antiemetics / Q000008:administration & dosage; D000077608:Aprepitant; D059248:Chemoradiotherapy / Q000009:adverse effects / Q000379:methods; D005260:Female; D006801:Humans; D009025:Morpholines / Q000008:administration & dosage*; D009325:Nausea / Q000209:etiology / Q000517:prevention & control*; D010865:Pilot Projects; D011446:Prospective Studies; D002583:Uterine Cervical Neoplasms / Q000628:therapy*; D014839:Vomiting / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000932:Antiemetics; D009025:Morpholines; D000077608:Aprepitant
keywords: Aprepitant; Chemoradiotherapy; Cisplatin; Nausea; Vomiting